Chief Business Officer
Chief Business Officer at Kymera Therapeutics, Inc., filing insider transactions between 2026-04-09 and 2026-07-01.
| SEC ↗ |
| 2026-06-22 | KYMR | Sale | 2,500 | $99.00 | $248K | SEC ↗ |
| 2026-04-14 | KYMR | Sale | 1,347 | $90.00 | $121K | SEC ↗ |
| 2026-04-10 | KYMR | Sale | 2,000 | $87.35 | $175K | SEC ↗ |
| 2026-04-09 | KYMR | Sale | 2,500 | $89.00 | $223K | SEC ↗ |
| 2026-04-09 | KYMR | Sale | 3,094 | $86.62 | $268K | SEC ↗ |
| 2026-04-09 | KYMR | Sale | 2,670 | $87.11 | $233K | SEC ↗ |